And now for something completely indifferent: Recent Episodes
None
Welcome to “And now for something completely indifferent® ”, a Canadian health benefits industry podcast, brought to you by your friends at Green Shield Canada (GSC).
In episode 31, host David Willows invites returning pharmacy strategy guests Ned Pojskic (aka GSC’s “Outspoken Evangelist”) and super-pharmacist Leila Mandlsohn to discuss a topic near and dear to our hearts… Canada’s progress with biosimilar adoption. They discuss provincial drug plan movement, the ongoing (and curious) hesitancy from private payors, the patient experience, and the biosimilars pipeline.
In episode 30, host David Willows chats with returning guest Chris Bonnett, Principal Consultant at H3 Consulting, and first-time contributor Helen Stevenson, Founder and CEO of Reformulary Group, about (…to be blunt…) why the pharmacare debate never advances and what collaborative and practical approaches could help “fill the gaps” for Canadians without adequate drug coverage.
In this episode, host David Willows once again interviews Dr. Carlos Quiñonez, associate professor and program director at the Faculty of Dentistry, University of Toronto. They re-visit the state of oral health care and talk about the Green Door Project – the largest-ever dental public health service and research program in Canadian history.
In this episode, GSC’s David Willows interviews CLHIA president and CEO Stephen Frank to reminisce about 2020 and forecast what 2021 will bring, namely a possible federal election, the pharmacare debate revisited and more Covid-19.
In episode 27, we invite GSC’s Ned Pojskic and Mike Sullivan of Cubic Health Inc. to kick off 2021 with a look at where MC has been and where it might be headed.
In episode 26 of GSC’s podcast, we bring back pharmacist and researcher John Papastergiou, as well as Ned Pojskic, GSC’s leader of pharmacy and health provider relations, to talk about their research project that studied the impact of pharmacogenomics testing on patient outcomes.
In episode 25, host David Willows and producer Sarah Murphy chat with two guests (virtually) to talk about pharmacare – Chris Bonnett, Principal Consultant at H3 Consulting (and recent PhD recipient) and regular contributor Stephen Frank, CLHIA President and CEO.
In episode 24, host David Willows and producer Sarah Murphy invite Dr. Carlos Quinonez to the podcast studio to talk about the state of dentistry in Canada in 2020 and how it impacts benefits plans.
In episode 23, host David Willows and producer Sarah Murphy bring back GSC writer Carley Parekh to discuss her latest edition of g(sc) TALK, which offers some practical (and evidence-based) advice on how to best adjust to pandemic life.
In episode 22, host David Willows and producer Sarah Murphy bring back GSC writer Carley Parekh to discuss her recent edition of g(sc) TALK which takes a critical look at the world of diets and diet culture.
In episode 21, producer Sarah Murphy and host David Willows welcome (for the third time) CLHIA’s President and CEO Stephen Frank to talk about industry happenings – pharmacare, CCIR, fraud, and more.
In episode 20, producer Sarah Murphy and host David Willows welcome back GSC writer Carley Parekh to the podcast studio to share the research behind her “Gut feelings” article in (g)sc TALK.
In Episode 19, producer Sarah Murphy and host David Willows welcome Dr. Danielle Martin to the podcast studio to discuss better approaches to health care.
In episode 18, producer Sarah Murphy and host David Willows welcome GSC writer Carley Parekh to the podcast studio to share the research behind her “Health by the numbers” article in (g)sc TALK.
In episode 17, producer Sarah Murphy and host David Willows welcome special guest Dr. Luca Pani from the University of Miami and Ned Pojskic, GSC’s leader of pharmacy & health provider relations, to discuss the promise and challenging financial impact of gene therapy.
In episode 16, host David Willows welcomes Faizel Alladina from People Corporation and Mike McClenahan from BBD. From the advisor/TPA perspective, they discuss the changing benefits environment, the emerging focus on technology and customer experience, and their perspectives on G19 compensation disclosure.
In episode 15 (yes, it’s been a while!), host David Willows speaks with Globe & Mail contributors Wayne MacPhail and Paul Benedetti about the schism that exists in the Canadian chiropractic community. It is a cautionary tale on the limits of self-regulation.
In episode 14, hosts Sarah and David welcome two guests to the studio – Ben Harrison, Partner at Portag3 Ventures, and GSC’s Director of Strategic Innovation, Erin Crump. They discuss the world of Fintech/Insurtech start-ups/new ventures, the emerging focus on the customer experience, and whether the word “disruption” is a meaningful one.
In Episode 13, hosts Sarah Murphy and David Willows sit down with the CLHIA’s President and CEO Stephen Frank to talk about a wide range of meaty industry topics, including one of the most talked about industry initiatives, CLHIA’s G(uideline)19.
In episode 12, hosts Sarah and David, along with guests Erin Crump (GSC’s Leader of Strategic Innovation) and Ned Pojskic (GSC’s Leader of Pharmacy and Health Provider Strategy), discuss why private health benefits plans have been so static for so long, and why measuring value (health outcomes) for spend has not been made a priority in Canada.
In episode 11, hosts Sarah and David welcome guest Steve Mast, President and Chief Innovation Officer at Delvinia. Steve defines the concept of “customer experience” and how employee engagement contributes to it.
In episode 10, hosts Sarah and David celebrate the recording of the tenth podcast and discuss the topic of value-based benefits with guests Ned Pojskic, GSC’s Leader of Pharmacy and Health Provider Relations, and William Chung, Shoppers Drug Mart’s Senior Vice President of Payor Partnerships and Pricing.
In Episode 9, hosts Sarah and David welcome friend and colleague Peter Gove back into the studio along with Founder and CEO of ManagingLife, Tahir Janmohamed, to discuss the complex topic of chronic pain.
In episode 8 of GSC’s podcast, we talk to pharmacist and researcher John Papastergiou, as well as Ned Pojskic, our pharmacy strategy leader, about the research project GSC is currently sponsoring, looking at pharmacogenomics testing and patient outcomes in a community pharmacy.
In episode 7, hosts Sarah Murphy and David Willows welcome guests Ned Pojskic, GSC’s Leader, Pharmacy and Health Provider Relations, and Cheryl Koehn, the Founder and President of patient organization Arthritis Consumer Experts into the studio to talk biosimilars.
In episode 6, hosts Sarah Murphy and David Willows invite GSC’s health innovation leader Peter Gove back to the studio to discuss financial health and its impact on broader mental health. Sarah and David also introduce the first edition of the Ask the Pharmacist podcast, this one addressing the quality of care in Canadian pharmacies and what the average patient can do to maximize the experience.
In episode 5, hosts Sarah Murphy and David Willows welcome to the studio Stephen Frank, President and CEO of the Canadian Life and Health Association (CLHIA).
Hosts Sarah Murphy and David Willows invite guests Amos Adler and Bill Simpson from MEMOTEXT to explore the world of Artificial Intelligence and Machine Learning and its potential relevance in the health benefits space.
Episode 3 of “And Now for Something Completely Indifferent…” is all about medical marijuana, and it features GSC experts and special guest Mike Sullivan of Cubic Health Inc.
In episode 2, David Willows (GSC's chief innovation & marketing officer) interviews Dr. Peter Farvolden (clinical director of CBT Associates and BEACON) about his insider take on mental health treatment in Canada and then challenges Peter Gove (GSC’s health innovation leader) to define Mindfulness and defend the science behind it.
In this first episode of “And Now For Something Completely Indifferent”, David Willows talks with Peter Gove and Erin Crump about highlights from the 2017 GSC health study, “Come Health or High Water”…